TIAM1 and retinoblastoma: The over expression of Tiam1 in breast carcinoma, nasopharyngeal carcinoma, hepatocellular carcinoma, renal cell carcinoma, retinoblastoma, colorectal carcinoma, lung and prostate cancer has been previously reported [16], [17], [18], [19], [20], [21], [22].